Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
43
RHHBY Quote, Financials, Valuation and Earnings
Last price:
$52.42
Seasonality move
:
-2.63%
Day range:
$52.42 - $53.00
52-week range:
$34.17 - $52.59
Dividend yield:
2.64%
P/E ratio:
30.95x
P/S ratio:
4.75x
P/B ratio:
6.76x
Volume:
2.9M
Avg. volume:
2.8M
1-year change:
50.26%
Market cap:
$335B
Revenue:
$68.7B
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingRoche Holding AG has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 4 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $52.84, Roche Holding AG has an estimated upside of 0.49% from its current price of $52.53.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $45.00 representing 100% downside risk from its current price of $52.53.
Fair Value
-
According to the consensus of 8 analysts, Roche Holding AG has 0.49% upside to fair value with a price target of $52.84 per share.
RHHBY vs. S&P 500
-
Over the past 5 trading days, Roche Holding AG has overperformed the S&P 500 by 2.64% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Roche Holding AG does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Roche Holding AG has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Roche Holding AG reported revenues of --.
Earnings Growth
-
Roche Holding AG has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Roche Holding AG reported earnings per share of --.
Enterprise value:
274.6B
EV / Invested capital:
--
Price / LTM sales:
4.75x
EV / EBIT:
15.87x
EV / Revenue:
3.68x
PEG ratio (5yr expected):
--
EV / Free cash flow:
17.93x
Price / Operating cash flow:
23.83x
Enterprise value / EBITDA:
12.85x
Gross Profit (TTM):
$52.2B
Return On Assets:
10%
Net Income Margin (TTM):
16.81%
Return On Equity:
28.65%
Return On Invested Capital:
14.32%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2005-12-31 | 2006-12-31 | 2007-12-31 | 2006-12-31 | 2007-12-31 | |
| Income Statement | ||||||
| Revenue | $28.4B | $33.6B | $38.5B | -- | $10.7B | |
| Gross Profit | $20.3B | $24.4B | $27B | -- | -- | |
| Operating Income | $6.3B | $8.4B | $10.4B | -- | -- | |
| EBITDA | $8.2B | $10.4B | $12.5B | -- | -- | |
| Diluted EPS | $0.69 | $0.90 | $1.16 | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $33.9B | $31.8B | $34.4B | $37.4B | $44.7B | |
| Total Assets | $95.4B | $90.9B | $93.8B | $106.6B | $118.7B | |
| Current Liabilities | $27.4B | $28.7B | $29.1B | $29.6B | $34.5B | |
| Total Liabilities | $50.4B | $60.6B | $60.1B | $70B | $77.3B | |
| Total Equity | $45B | $30.3B | $33.7B | $36.6B | $41.4B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-25 | 2024-12-25 | 2024-12-25 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
RHHBY
Sector
Market Cap
$335B
$28.1M
Price % of 52-Week High
99.99%
51.39%
Dividend Yield
2.64%
0%
Shareholder Yield
3.91%
-1.49%
1-Year Price Total Return
50.72%
-17.13%
Beta (5-Year)
0.460
0.518
Dividend yield:
2.64%
Annualized payout:
$1.35
Payout ratio:
-76.57%
Growth streak:
5 years
Technicals
8-day SMA
Buy
Level
$51.13
200-day SMA
Buy
Level
$42.09
Bollinger Bands (100)
Buy
Level
40.06 - 47.78
Chaikin Money Flow
Buy
Level
2.6M
20-day SMA
Buy
Level
$49.76
Relative Strength Index (RSI14)
Buy
Level
69.48
ADX Line
Buy
Level
22.52
Williams %R
Sell
Level
-0.112
50-day SMA
Buy
Level
$46.31
MACD (12, 26)
Buy
Level
13.62
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
8.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.8146)
Buy
CA Score
(Annual)
Level (-0.2068)
Buy
Beneish M-Score
(Annual)
Level (-3.0502)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-1.0146)
Buy
Piotroski F Score
(Annual)
Level (6)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
Stock Forecast FAQ
In the current month, RHHBY has received 3 Buy ratings 4 Hold ratings, and 1 Sell ratings. The RHHBY average analyst price target in the past 3 months is $52.84.
-
Where Will Roche Holding AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that Roche Holding AG share price will rise to $52.84 per share over the next 12 months.
-
What Do Analysts Say About Roche Holding AG?
Analysts are divided on their view about Roche Holding AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Roche Holding AG is a Sell and believe this share price will drop from its current level to $45.00.
-
What Is Roche Holding AG's Price Target?
The price target for Roche Holding AG over the next 1-year time period is forecast to be $52.84 according to 8 Wall Street analysts, 3 of them rate the stock a Buy, 1 rates the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is RHHBY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Roche Holding AG is a Hold. 4 of 8 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of RHHBY?
You can purchase shares of Roche Holding AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Roche Holding AG shares.
-
What Is The Roche Holding AG Share Price Today?
Roche Holding AG was last trading at $52.42 per share. This represents the most recent stock quote for Roche Holding AG. Yesterday, Roche Holding AG closed at $52.53 per share.
-
How To Buy Roche Holding AG Stock Online?
In order to purchase Roche Holding AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get RHHBY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RHHBY
Sector
P/E ratio
30.95x
23.89x
PEG ratio
--
-0.01x
P/B ratio
6.76x
1.81x
Price / LTM sales
4.75x
1.59x
Growth Metrics
RHHBY
Sector
Revenue growth
--
4.62%
Earnings growth
--
11.06%
Revenue (5-year growth)
2.12%
6.5%
Earnings forecast
--
-$0.21
Profitability
RHHBY
Sector
Profitability FY 2024
$50.5B
$3.6M
Return on invested capital
14.32%
-31.84%
Return on assets
10%
-27.96%
Return on equity
28.65%
-37.63%
Earnings Date
Last Earnings Date
Jul
24
Next Earnings Date
Jan
29
Estimated Next Earnings Date
Oct
23
Balance Sheet
RHHBY
Sector
Total cash
$15.1B
$26.4M
Short term investments
$11.4B
$25.7M
Total assets
$112.3B
$76.9M
Long term debt
--
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
